Selecta Biosciences | Our Nanomedicine Technology: Targeted Immunotherapies and Vaccines
Werner Cautreels, CEO of Selecta Biosciences, provides an overview of Selecta #39;s approach to developing a new class of next-generation vaccines and immunother...
By:
Selecta BiosciencesOriginal post:
Selecta Biosciences | Our Nanomedicine Technology: Targeted Immunotherapies and Vaccines - Video